Source link : https://newshealth.biz/health-news/drug-combo-shows-benefits-in-fit-patients-with-acute-myeloid-leukemia/

(MedPage Today) — ORLANDO — Azacitidine and venetoclax (Venclexta) significantly improved event-free survival (EFS) in newly diagnosed fit adults with acute myeloid leukemia (AML) compared with conventional induction chemotherapy, a phase II… Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118890 Author : Publish date : 2025-12-08 18:49:00 Copyright for syndicated content belongs to the linked Source.

The post Drug Combo Shows Benefits in Fit Patients With Acute Myeloid Leukemia first appeared on News Health.

—-

Author : News Health

Publish date : 2025-12-08 18:49:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Exit mobile version